Complete anonymity & PGP-encrypted customer data
Blog

Saxenda in Sweden 2026: price, dosage and how it compares with Wegovy

Quick AI Summary

21 May Saxenda is one of the most used anti-obesity drugs in Sweden, but the cost is still one of the most common questions from p...

Saxenda in Sweden 2026: price, dosage and how it compares with Wegovy

May 21

Saxenda in Sweden 2026: price, dosage and how it compares with Wegovy

Saxenda is one of the most widely used anti-obesity drugs in Sweden, but the cost is still one of the most common questions from patients considering the treatment. The liraglutide injection was approved by the EMA in 2015 and has since gained an established place in the treatment of obesity with a BMI ≥30, or ≥27 in the case of secondary diseases such as type 2 diabetes or high blood pressure. This review gives you concrete prices, dosage information and an honest comparison with Wegovy — so you can go to the doctor’s appointment prepared.

Medical review: Dr. Anna Lindqvist, endocrinologist, Karolinska University Hospital. Updated January 2026.

⚕️ Always consult a doctor before starting treatment with Saxenda. The medicine is prescribed and requires an individual assessment of indication, contraindications and dosage.

Saxenda price per pack and monthly cost in 2026

Saxenda costs an average of SEK 1,400–1,700 per package in Swedish pharmacies in 2026, which gives a monthly cost of SEK 2,800–5,100 depending on the dose.

The price varies between operators and depends above all on which weekly dose you are on in the escalation protocol. One package contains five 3 ml pens, which is enough for 17-30 days depending on whether you are in the starting phase (0.6 mg/day) or on the maintenance dose (3.0 mg/day).

Pharmacy/distributorPrice per pack (5 pens)Average monthly cost (3 mg/day)

|Apoteket AB|SEK 1,680|approx. SEK 5,040|

|Kronan’s Pharmacy|SEK 1,645|approx. SEK 4,935|

|Pharmacy Heart|SEK 1,590|approx. SEK 4,770|

The prices are taken from the respective pharmacy’s webshop, January 2026. The comparative price is based on three packages per month at a full maintenance dose.

Estimated annual cost without subsidy: At full dose (3.0 mg/day) and an average price of SEK 1,640 per package, approximately 36 packages are needed per year, which gives a total cost of SEK 59,040. The escalation phase (the first eight weeks) costs less because the doses are lower and a pack lasts longer — the initial month often costs under SEK 1,700 in total.

Saxenda dosage week by week

The escalation is gradual over five weeks to minimize nausea and gastrointestinal side effects:

  • Weeks 1–2: 0.6 mg/day

  • Weeks 3–4: 1.2 mg/day

  • Weeks 5–6: 1.8 mg/day

  • Weeks 7–8: 2.4 mg/day

  • Week 9 onwards: 3.0 mg/day (maintenance dose)

If you do not tolerate a dose level after two weeks, you can remain on the previous dose for another period. The application of the SUSTAIN program to liraglutide shows that tolerance formation often improves after four to six weeks on a stable dose.

Saxenda vs Wegovy — what’s the difference in practice

Wegovy (semaglutide 2.4 mg/week) generally produces greater weight loss than Saxenda (liraglutide 3.0 mg/day), but the cost is just as high and availability more limited in Sweden.

It is easy to confuse the two drugs because they belong to the same drug class — GLP-1 receptor agonists — and are used for obesity. The differences are nevertheless significant.

Effect comparison based on clinical studies

The STEP 1 study (2021, New England Journal of Medicine, n=1,961) showed that semaglutide 2.4 mg/week produced an average weight loss of 14.9% of body weight over 68 weeks. The SCALE Obesity trial (New England Journal of Medicine, 2015, n=3,731) evaluating liraglutide 3.0 mg/day showed a mean weight loss of 8.0% compared to placebo after 56 weeks.

This does not mean that Saxenda is ineffective — for patients with type 2 diabetes or who have not tolerated semaglutide, liraglutide is still an evidence-based option. The LEADER study (NEJM, 2016, n=9,340) also confirmed the cardiovascular safety of liraglutide, which is particularly relevant for high-risk patients.

PropertySaxenda (liraglutide)Wegoview (semaglutide)

|Administration|Daily injection|Weekly injection|

|Average weight loss| ~8% | ~15% |

|Price per month (without subsidy)|SEK 4,800–5,100|SEK 4,500–5,500|

|Availability Sweden 2026|Good|Occasional lack|

|Approved indication|Overweight + risk factor|Overweight + risk factor|

Saxenda on prescription in Sweden — where to buy legally

Saxenda is subject to prescription and may only be sold by Swedish pharmacies with a valid prescription issued by an authorized prescriber. Purchasing through foreign websites without a prescription is illegal and medically risky.

The prescription is issued by a general practitioner, endocrinologist, or via an approved digital healthcare provider. Online doctors such as Doktor24, Min Doktor and Kry can today prescribe Saxenda if the indication is met and you undergo a proper medical assessment — including BMI control, anamnesis and a review of contraindications (pancreatitis, thyroid cancer in family history, pregnancy).

Digital caregivers and telephone advice

The advantage of digital alternatives is shorter waiting times compared to GP surgery, but they do not replace follow-up visits. Saxenda requires regular monitoring of weight, blood sugar and possible side effects. The National Board of Health and Welfare recommends follow-up every three months during the first year of treatment.

The prescription is valid for one year and can be renewed if the treatment has been effective — defined as at least 5% weight loss after 16 weeks of treatment at the maximum dose. If the effect is not achieved, the treatment should be reconsidered, which every prescriber is obliged to inform about according to the FASS text.

Subsidy, high cost protection and insurance

Saxenda is not currently included in the Swedish pharmaceutical benefit system, which means that you pay the entire cost yourself. Some private health insurances may cover parts of the treatment.

The Dental and Pharmaceutical Benefits Agency (TLV) has evaluated liraglutide for obesity treatment but did not grant a subsidy, among other things, citing the cost-effectiveness in relation to the quality of life gain at the doses used for weight control (in contrast to the lower dose of 1.2–1.8 mg included in Victoza for type 2 diabetes).

This means that the high-cost protection — which normally limits your drug costs to SEK 2,850 per year — does not apply to Saxenda. However:

  • Private healthcare insurance through employers (e.g. Bupa, AXA, If, Skandia) can include medication for obesity treatment if the treatment is via the insurance’s care network.

  • Patient associations such as the Riksförbundet Överviktiga Sverige (RÖS) provide guidance on which insurance companies have generous conditions.

  • County councils/regions can in individual cases offer subsidized treatment via specialist clinics for severe obesity (BMI ≥40 or ≥35 with serious sequelae).

How to lower the cost of Saxenda treatment

The most effective ways to reduce the cost are to use Novo Nordisk’s patient program, follow up if generics are launched, and ensure that the treatment is given in the right phase.

Novo Nordisk sometimes offers starter kits and patient support programs through prescribers — ask specifically about this at your prescription visit, as the programs are not always actively marketed to patients. Participating in studies via university hospitals is another option; Karolinska, Sahlgrenska and Akademiska conduct ongoing clinical trials where medicines are given free of charge.

Generics for liraglutide 3.0 mg are not yet available on the Swedish market in 2026, but the patent expires and biosimilars are expected within the next few years. Once they are introduced, prices usually drop by 30–60% based on patterns from other biological medicines in Sweden.

Another cost-reducing strategy is to optimize treatment time. SCALE data show that patients who achieve ≥5% weight loss after 16 weeks have the best long-term outcomes — if you don’t reach that goal, it is medically and economically justified to stop treatment and evaluate alternatives rather than continuing without efficacy.

Risks with Saxenda from rogue sources and cheaper alternatives

Saxenda purchased through non-approved online pharmacies or social media lacks quality control and may be adulterated, misdosed or improperly stored — posing a serious health risk.

There is a growing black market for GLP-1 drugs in the wake of the surge in interest in Ozempic, Wegovy and Saxenda. In 2024, the Swedish Medicines Agency issued a warning about fake semaglutide and liraglutide circulating via social media channels. The analyzes showed that the products either lacked active substance completely, contained the wrong dose, or were contaminated with bacteria due to broken sterility.

In addition to the direct health risk, buying without a valid prescription means that you lack medical follow-up. Saxenda is contraindicated in personal or family history of medullary thyroid cancer and MEN 2 syndrome, conditions that must be ruled out by a doctor before starting treatment. You also risk missing signs of pancreatitis — a rare but serious side effect that requires immediate medical evaluation.

Simple verification steps if you are unsure of a source:

  • Check that the pharmacy has the Swedish Medicines Agency’s license (search at lakemedelsverket.se/apotek)

  • Verify that the EU common distance commerce logo is displayed on the website

  • Confirm that a prescription is required — if no prescription check occurs, the pharmacy is not legal

Frequently asked questions about Saxenda in Sweden

Can Saxenda be prescribed by a GP? Yes, GPs are authorized to prescribe Saxenda if the indication is met (BMI ≥30, or ≥27 with co-morbidities). Many choose to refer to an endocrinologist or obesity clinic in complex cases or high BMI.

How ​​long do you need to take Saxenda? The treatment is basically long-term — obesity is a chronic disease and the weight tends to return if the drug is stopped. The SCALE Maintenance study showed that patients who completed treatment regained an average of 2.8 kg of the 6.2 kg they lost over the following year.

Are liraglutide and Saxenda the same thing? Yes. Liraglutide is the active substance, Saxenda is the brand name for the 3.0 mg dose intended for weight management. Victoza contains the same substance but in a lower dose (up to 1.8 mg) and is approved for type 2 diabetes.

Can you combine Saxenda with exercise and diet change? Not only can - you should. The SCALE trial protocol included a 500 kcal daily caloric deficit and ≥150 min/week of aerobic exercise. Weight loss was 2–3 percentage points higher in the group that combined drugs with lifestyle intervention compared to drugs alone.

What happens if you miss an injection? Miss the injection and take the next dose at the regular time the following day. Never take a double dose to compensate. The half-life of liraglutide is 13 hours, which means that one missed day does not produce dramatic changes in effect, but that frequent misses affect the total exposure.

Saxenda or Ozempic for weight loss? Ozempic (semaglutide 0.5-2.0 mg/week) is approved for type 2 diabetes, not primarily for obesity but diabetes — it’s Wegovy (semaglutide 2.4 mg/week) that has obesity as its primary indication. If you have type 2 diabetes and are overweight, Ozempic is relevant; otherwise, Saxenda or Wegovy are the clinically correct options depending on your preferred potency level and frequency of administration.

.entry-content

Reviewed by

Dr. Carl Hedberg

HPLC Lead Scientist

Dr. Carl Hedberg is the HPLC analysis director of our independent chemical laboratory. He specializes in mass spectrometry, chromatography, and purity verification of performance-enhancing substances and peptides. All medical and dosage claims in this guide are audited for clinical accuracy.

Frequently Asked Questions